thirty patients clinically localized adenocarcinoma prostate underwent simultaneous staging pelvic lymphadenectomy interstitial irradiation patients followed eighteen months regard progression disease development complications upstaging stage d1 virtue discovering pelvic node involvement noted NUMBER patients NUMBER cent subsequent disease progression defined development bone soft tissue metastasis seen NUMBER NUMBER upstaged patients average time progression NUMBER months stage d1 patients died average time death NUMBER months NUMBER patient lymphadenectomy negative experienced disease progression died adjuvant chemotherapy cyclophosphamide doxorubicin hydrochloride given NUMBER upstaged patients NUMBER did disease progress contrast NUMBER NUMBER upstaged patients receiving chemotherapy metastatic disease developed average time progression NUMBER months attempt improve local tumor control achieved interstitial irradiation NUMBER patients received additional external beam radiation therapy prostate doses ranging NUMBER NUMBER rad sixteen complications NUMBER patients NUMBER cent seen patients receiving added external beam irradiation long term long term